In addition, we found a correlation between SLC2A3 and a variety of immune cells, such as CD4+ and CD8+T cells, macrophages, etc. Studies have suggested that SLC2A3 promotes the growth and drug resistance of gastric cancer cells by increasing the infiltration of M2 macrophages (57). Here, CD4 is linked to gastric cancer.